Up a level |
Broeckelmann, Paul J., Goergen, Helen, Keller, Ulrich, Meissner, Julia, Ordemann, Rainer, Halbsguth, Teresa V., Sasse, Stephanie, Soekler, Martin, Kerkhoff, Andrea, Mathas, Stephan, Huettmann, Andreas, Bormann, Matthias, Zimmermann, Andreas, Mettler, Jasmin, Fuchs, Michael, von Tresckow, Bastian, Baues, Christian, Rosenwald, Andreas, Klapper, Wolfram, Kobe, Carsten, Borchmann, Peter and Engert, Andreas (2020). Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial. JAMA Oncol., 6 (6). S. 872 - 881. CHICAGO: AMER MEDICAL ASSOC. ISSN 2374-2445
Halbsguth, Teresa V., Boell, Boris, Borchmann, Peter and Diehl, Volker (2011). The Unique Characteristics and Management of Patients Over 60 Years of Age with Classic Hodgkin Lymphoma. Curr. Hematol. Malig. Rep., 6 (3). S. 164 - 172. PHILADELPHIA: CURRENT MEDICINE GROUP. ISSN 1558-822X
Halbsguth, Teresa V., Nogova, Lucia, Mueller, Horst, Sieniawski, Michal, Eichenauer, Dennis A., Schober, Thomas, Nisters-Backes, Hiltrud, Borchmann, Peter, Diehl, Volker, Engert, Andreas and Josting, Andreas (2010). Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood, 116 (12). S. 2026 - 2033. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020